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ABSTRACT 
STUDIES ON THE ROLE OF CREB AS A MEDIATOR OF NEUROTROPHIN-3 
ACTION IN OLIGODENDROCYTES 
Jamie R .  Johnson, B .S .  
A thesis submitted in partial fulfi l lment of the requirements for the degree of M.S .  at 
Virginia Commonwealth University. 
Virginia Commonwealth University, 2000 
Thesis Director: Cam1en Sato-Bigbee, PhD., Assistant Professor, Department of 
Biochemistry and Molecular Biophysics 
In the central nervous system (CNS), oligodendrocytes (OLGs) are the cells 
responsible for producing the myelin membrane which allows for the saltatory conduction 
of neuronal impulses. Vfe have previously shown that CREB (cAMP response element 
binding protein), a transcription factor that belongs to a large family of bZip (basic 
leucine zipper) proteins, could be a mediator of neuronal signals that, coupled to different 
signal transduction pathways, may play different regulatory roles at specific stages of 
ol igodendrocyte development. We have found before that, in committed OLGs, CREB 
activation by phosphorylation can be triggered by p-adrenergic stimulation and appears to 
play a role in the induction of OLG differentiation by cAMP. In contrast, in OLG 
precursor cells, C REB phosphorylation is stimulated by neuroligands that increase 
x 
calcium levels by a process that involves a mitogen activated protein kinase (MAPK)/ 
protein kinase C (PKC) pathway. This observation suggested that, at this early 
developmental stage, CREB could play a role in regulating cell proliferation. In support 
of this hypothesis, we have now found that a rapid and dramatic stimulation of CREB 
phosphorylation is one of the earliest events that precedes the increase in cell prol iferation 
that is observed when OLG precursors are treated with neurotrophin-3 (NT-3) .  
Moreover, our present results also showed that down-regulation of CREB expression in 
the OLG precursors abolished the in(Jrease in cell proliferation that is observed when the 
cultures are treated with NT-3 . Experiments in which CREB phosphorylation was 
investigated in the presence of different kinase inhibitors indicated that the activation of , 
this transcription factor in the presence of NT-3 is mediated by the concerted action of 
MAPK- and PKC-dependent signal transduction pathways. Additional experiments using 
specific inhibitors of protein kinase A (PKA), Ca2+ -calmodulin-dependent kinase 
(CamK) and phosphatidylinositol 3-kinase (PI3 K) pathways suggested that these k inases 
may not play a significant role in mediating CREB phosphorylation by NT-3 . However, 
further studies are required for more conclusive results about these kinases. Thus, our 
present results support the idea that stimulation of OLG proliferation by NT -3 involves 
the CREB transcription factor and its activation by MAPK- and PKC-dependent signal 
transduction pathways. 
INTRODUCTION 
The myeli n  membrane 
The myelin sheath is a highly modified and specialized membrane structure that 
wraps around axons and allows for the saltatory conduction of neuronal impulses. The 
myelin membrane surrounds the axons in a spiral fashion to form a multi-lamellar 
structure (Fig I ) . In the central nervous system (eNS), myelin is formed by the extended 
plasma membrane of the oligodendrocytes (OLGs). In the peripheral nervous system 
(PNS), however, the Schwann cells synthesize this membrane. The myelin membrane 
and the areas of the axon that are myelinated are collectively called the internodes. These 
internodes are separated by regions of the axon that are bare and are known as the nodes 
of Ranvier (Raine, I 984a). 
In the PNS, the myelin membrane of each internode is made by the Schwam1 cel l .  
During development the Schwann cel ls  migrate with the peripheral nerve fibers which 
begin to be myelinated after reaching the diameter of 1 -2 Ilm. A single Schwann cell wi l l  
then wrap around an axon as the Schwam1 cell 's cytoplasmic ridge folds around the axon 
and underneath its own membrane on the other side. This expanding portion of the 
membrane, called the mesaxon, continues to concentrically encircle the axon as the 
cytoplasm is extruded, thus condensing the membrane surfaces and producing compact 
myelin .  By this process, the cell body of the Schwann cell remains closely apposed to the 
1 
2 
Figure 1. An il lustration of OLGs myelinating axons in the eNS. (A) OLG cell body 
with many processes myelinating various axons. (B) Cross section of an axon with 
concentrically wrapped myelin membrane. 
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axon (Raine, 1 984a). 
The myelination process in the CNS by the OLGs is similar to that of the 
Schwann cel l .  However, the major difference is that OLGs have arborized processes that 
extend from their soma; it is the ends of these processes that come into contact with the 
axons forming the myelin membrane around them. By this process, each OLG in the 
CNS could myelinate 40 or more separate axons with its cell body being some distance 
away from the axons (Davidson et a I . ,  1 970).  
The functional role of the myelin membrane, as an electrical insulator, was 
speculated as early as 1 878 by Ranvier. Currently, it is accepted that the myelin 
membrane allows for the rapid form of neuronal impulse propagation known as saltatory 
conduction. In unmyelinated nerve fibers, the neuronal impulses are propagated in such a 
manner that a local circuit is created in the axonal membrane in which the resulting 
current travels by depolarizing the adjacent area of the membrane in a sequential and 
continuous fashion. However, during saltatory conduction, only the nodes of Ranvier 
participate in the depolarization while the myelin membrane insulates the rest of the axon. 
Furthermore, the sodium channels required for the depolarization are localized at the 
nodes of Ranvier (Waxman et aI . ,  1 993) .  
The presence of myelin not only saves energy by resulting in less sodium flux due 
to the localization of the sodium channels at the nodes of Ranvier, but also greatly 
increases the conduction velocity of the neuronal impulse by producing a current that is 
saltatory. It also has space saving properties by decreasing the axonal diameter 
requirements which, in theory, should be proportional to the conduction velocity. To 
better understand this, if unmyelinated axons were to replace the myelinated ones, in 
order to maintain the same conduction velocity, the human spinal cord would have to be 
as thick as a tree trunk (Ritchie, 1 984) .  
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The myelin membrane is a particularly good insulator, not only because of its 
multi-lamellar structure, but also due to its composition, characterized by a high lipid to 
protein ratio, of about 80 to 20.  Besides cholesterol, a major lipid component of myelin 
is cerebroside, also known as galactosylceramide. About one-fifth of these galactolipids 
also occur as sulfatides in which the 3-hydroxyl group on the galactose moiety of 
cerebrosides is sulfated (Norton and Cammer, 1 984). Because of their quantity, it was 
believed that these galactolipids were essential for myelin formation. However, a mouse 
knockout model lacking the last step in cerebroside biosynthesis revealed that the myelin 
formed was relatively normal and that these galactolipids perhaps played a role in myelin 
stability, not myelin formation (Coetzee et aI . ,  1 996).  A minor component of myelin are 
gangliosides, which comprise approximately 0 . 1 to 0 .3% of the total lipid. These are 
complex glycolipids in which the ceramide backbone is esterified to three or more sugar 
residues. 
Myelin basic protein (MBP) is a major extrinsic membrane protein that exists 
both in the CNS and PNS myelin, however, it is more abundant in the CNS myelin 
comprising about 3 0%-40% of the total protein (Lees and Brostoff, 1 984) .  MBP exists 
on the cytoplasmic surface and is bel ieved to play a role in myelin compaction forming a 
structure known as the major dense line resulting from the apposition of the cytoplasmic 
face of the plasma membrane after the extrusion of the cytoplasm. Evidence for this 
comes from studies of a line of mutant mice called shiverer (Chernoff, 1 98 1 ) . It was 
shown that MBP is specifically deficient in these mice (Dupouey et aI . ,  1 979),  and that 
the major dense line in these animals is not evident, indicating uncompacted myelin 
(Privat et aI . ,  1 979) .  
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There are several variants of MBP that range from 2 1 . 5 kDa to 1 4 . 1 kDa which 
result from alternative splicing of a single gene containing at least seven exons 
(Takahashi et a I . ,  1 985;  Mentaberry et aI . ,  1 986; Roth et aI., 1 987; Newman et aI., 1 987). 
Although the functional roles of these variants are uncertain, changes in their ratios and 
differential expression suggest that some of these MBPs play a role during myelination. 
It has been suggested that the larger forms of MBP, 2 1 . 5 kDa and 17 kDa, which contain 
exon II may play an important role in the early period of myelin formation and/or OLG 
differentiation, since they are relatively more abundant at that time (Carson et a I . ,  1 983 ; 
Roth et aI . ,  1 987). 
Proteolipid protein (PLP) is another major constituent of the CNS myelin, 
comprising about 50% of its total protein (Lees and Brostoff, 1 984) .  Like MBP, PLP is 
not exclusive to the CNS. However, in the PNS, PLP is expressed at much lower levels 
in the Schwann cells and is also restricted to the cell cytoplasm (Puckett et aI., 1 987). In 
the CNS, PLP serves as a 30 kDa integral membrane lipoprotein that probably 
6 
participates in the formation of the intraperiod line, which results from the close 
apposition of the extra-cytoplasmic side of the adjacent plasma membranes in the 
concentric layers of myelin. Again, the evidence for this comes from a line of mutant 
mice called j impy (Sidman, (964) in which there are abnormalities in the intraperiod lines 
(Duncan et aI., (987) .  
Another protein component of myelin is the myelin-associated glycoprotein 
(MAG). Unlike MBP and PLP, MAG is expressed at low levels in the CNS and PNS 
myelin comprising about I % of the total protein (Quarles, 1 984) and is expressed at the 
periaxonal regions of the myelin sheath (Sternberger et aI . ,  1 979) .  MAG has a single 
transmembrane domain and five immunoglobulin-like domains, a structure similar to the 
one corresponding to the neural cell adhesion molecule (NCAM) (Salzer et aI., (987).  In 
addition, treatment of cell cultures with anti-MAG antibodies blocks neuron­
oligodendrocyte and o ligodendrocyte-oligodendrocyte adhesion (Poltorak et a I . ,  1 987). 
Thus, these observations support the notion that MAG serves as an adhesion molecule 
that may function in cell to cell signaling, perhaps directing the initiation of myelination. 
An interesting aspect of the cell to cell signaling properties of MAG is the fact that it may 
not only direct the myelination of an axon, but it may also control the growth of the axon 
itself as MAG is one of the molecules in the CNS that has been shown to inhibit neurite 
7 
outgrowth in tissue cultures (Mukhopadhyay et al . ,  1 994). 
Another minor protein component of CNS myelin is the myelin-oligodendrocyte 
glycoprotein (MOG) (Gardinier et al . ,  1 992) .  Similar to MAG, MOG also contains an 
immunoglobulin-like domain. However, unlike MAG, MOG is localized on the surfaces 
of myelin and OLGs, which may indicate a function in transmitting extracellular 
information to the OLG interior. These protein components may play a role in certain 
pathologies of myelin. Much like MBP, MOG has been implicated as a target antigen in 
the autoimmune aspects of demyelinating neuropathies of the CNS such as multiple 
sclerosis. 
Multiple sclerosis 
Multiple sclerosis (MS) is a disease that currently afflicts an estimated 3 50,000 
persons in the United States (Anderson et al . ,  1 992) and is perhaps the most studied 
among a group of diseases of the CNS collectively known as demyelinating neuropathies 
characterized by a loss or damage of the myelin membrane. Consequently, one of the 
first neurological disabil ities usually caused by MS is optic neuritis resulting in impaired 
vision. Symptoms can remit and relapse while recovery may become incomplete as the 
disease progresses. Further loss of neurological control may occur as sufferers of the 
disease possibly face being wheelchair bound or, in extreme cases, death. 
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Currently, it is believed that the etiology of MS involves a genetically predisposed 
individual who becomes stimulated, perhaps by viruses during the late childhood, to have 
immunological reactions against the antigens found in the CNS, in particular in the 
myelin membrane and/or OLGs (Sorenson et a I . ,  1 998). Mutant or abnormal genes have 
not been l inked to MS,  however, a susceptibility al lele has been l inked to both familial 
and sporadic MS. (Yaouanq et aI . ,  1 997) .  
Family studies have also revealed a genetic susceptibility component. First­
degree relatives have a 20-fold increased risk compared to the population background 
(Sadovnick et a I . ,  1 993) ,  while a non-related child adopted into MS families retains the 
population background level of developing MS.  (Ebers et aI . ,  1 995) .  Also, siblings raised 
in separate households retain an equal chance of developing MS.  (Sadovnick et a I . ,  1 996) .  
Furthermore, the importance of genetics or perhaps other environmental factors is 
emphasized by the fact that Japan exhibits a lower occurrence of MS compared to other 
populations in similar latitudes (Hartung et aI . ,  1 990) .  Interestingly, if an individual 
moves from a high-risk area to a low risk area during chi ldhood, he or she wi l l  acquire 
the low risk of developing M S .  However, if that individual moves after adolescence, he 
or she retains the risk of the original location. (Kurtzke, 1 977) .  
The idea that the onset of MS could be stimulated by viral infections stems from 
the notion that MS is an autoimmunelinflammatory disease. Support for this notion 
comes from studies of experimental autoimmune enchephalomyelitis (EAE), an animal 
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model in which rats are immunized with components of the myelin membrane, i .e .  myelin 
basic protein (MBP) (Raine, 1 984b; Lassman, 1 983). According to this model,  T helper 
cells (CD4 positive, class II MHC restricted) recognize myelin antigens that are presented 
by cells of the macrophage lineage (microglia) and perhaps astrocytes resulting in 
inflammation that destroys myelin as well as damaging the OLGs. 
It is believed that in humans these T cells are generated by processes of molecular 
mimicry in which viral or bacterial antigenic fragments c losely resemble myelin 
components (Wucherpfennig et aI . ,  1 995) .  Furthermore, break down of the BBB is a 
characteristic component of M S  pathogenesis, albeit it is unknown whether this is an 
initiating factor or a secondary event to inflammation. However, it has been shown that 
activated T cells are able to cross the BBB (Hickey, 1 99 1 )  and is believed that they 
become resident in the CNS if they are specifically targeted to CNS antigens. The origins 
of the autoreactive T cells are not known, however the idea of molecular mimicry is 
supported by the studies finding that 1 29 bacterial and viral peptides were similar enough 
to MBP to trigger the activation of human T cell clones (Wucherpfennig et aI . ,  1 995) .  
Lastly, although these mechanisms of inflammation in MS are conjectural,  it has been 
shown that MS patients harbor autoreactive T cells (Hafler et aI . ,  1 985a; Hafler et aI . ,  
1 985b; Al legretta et aI . ,  1 990;  Allegretta et aI . ,  1 994). 
Due to its complex pathogenesis, understanding and trying to find therapies for 
MS involves various research disciplines which include genetics, epidemiology, 
1 0  
neuropathology, immunology and virology. In this project, we have focused our attention 
on the signaling cascade mechanism(s) involved in regulating the proliferation of the 
OLGs. It is hoped that a better understanding of these mechanisms will  eventually help to 
develop methods which wil l  aid in replenishing the OLGs that are damaged and/or lost in 
the course of diseases like MS .  
Oligodend rocyte development 
OLGs continue to divide throughout l ife ,  although at a much slower rate than 
during CNS development (Kaplan and Hinds, 1 980; McCarthy and Leblond, 1 988). 
Therefore, one might assume that diseases like MS where OLGs are damaged and/or lost 
may be easily cured by simply replenishing the cells. Unfortunately, the healing process 
is neither so easy nor simple. However, knowing that these cells could potentially 
regenerate gives hope into the possibil ity of developing treatment for diseases such as 
M S .  This has made the study of OLGs very important, because still little is known about 
the processes that regulate the proliferation and differentiation of these cells during 
normal CNS development. 
OLGs originate in the late gestational and early postnatal period from multi potent 
neural stem cells which are present in the peri ventricular zone and can generate neuronal, 
astroglial and oligodendroglial progenitors (Davis and Temple, 1 994; Marmur et aI . ,  
1 998; Vescovi et aI . ,  1 999;  Rogister et a I . ,  1 999; Tropepe et aI . ,  1 999) .  Cells of the OLG 
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lineage are initially identified in distinct regions of the ventricular and subventricular 
zone from where they migrate during differentiation (LeVine and Goldman 1 988; Curtis 
et aI . ,  1 988; Warf et aI., 1 99 1 ) . The different stages of differentiation can be 
distinguished by the sequential expression of different antigenic markers. Early 
prol iferative precursors express the embryonic neural cell adhesion molecule (E-NCAM) 
(Hardy and Reynolds, 1 99 1 ) . These cells later develop into early OLG progenitors or 0-
2A cells which were originally identified in cultures of developing optic nerve. 
The 0-2A cells were appropriately named so because, depending on the culture 
conditions, they are able to differentiate into either OLGs or type-2 astrocytes. When 
cultured in serum-free, chemically defined medium (COM), the 0-2A cells develop into 
OLGs. However, when these cells are grown in medium containing 1 0% fetal bovine 
serum, they develop into cells called type-2 astrocytes which express glial fibril lary acidic 
protein (GFAP), an astrocytic marker (Raff, 1 983 ) .  The existence of the type-2 astrocytes 
in vivo is controversial. Experiments in which 0-2A cells were labeled, in vitro, with fast 
blue dye and transplanted into neonatal rat brain, showed that all labeled cells developed 
into OLGs (Espinosa de los Monteros et aI., 1 993) .  This observation indicates the 
necessity for careful extrapolations of data obtained from inyitro experiments to an in 
vivo environment. 
The 0-2A progenitors were first identified by using the A2BS monoclonal 
antibody (Eisenbarth et al . , I 979; Raff et aI . ,  1 983) known to react with several 
gangliosides (Kundu et aI . ,  1 983; Fredman et aI . ,  1 984 ; Majocha et aI . ,  1 989). These cells 
have a simple, bi- or tripolar morphology (Temple and Raff, 1 986; Small et aI . ,  1 987), 
1 2  
express the intermediate fi lament vimentin (Raff et ai . ,  1 984), are very motile (Small et 
a i . ,  1 987) and prol iferate rapidly with a cell cycle time of approximately 1 8  to 20 hrs 
(Noble et a i . ,  1 988). The 0-2A cells later develop into the 04 positive progenitors 
characterized by their reactivity with the 04 antibody which recognizes cerebrosides and 
sulfatides (Sommer and Schachner, 1 982; Dubois-Dalcq, 1 987). Further differentiation 
of these progenitors into the mature committed OLGs follows the orderly expression of 
galactocerebroside (GC) (Raff et ai . ,  1 979), the myelin enzyme 2',3 '-cyclic nucleotide 3 '­
phosphodiesterase (CNPase) (McMorris, 1 983) and in a few days time, the myelin 
proteins MBP, PLP and MAG (Dubois-Dalcq et ai . ,  1 986). 
The factors that control the proliferation and differentiation of these cells have 
been the topic of intense scrutiny. It has been shown that platelet-derived growth factor 
(PDGF) is one of the major mitogens (Noble et ai . ,  1 988; Richardson et ai . ,  1 988), as well  
as a chemoattractant (Am1strong et a i . ,  1 99 1 )  for OLG progenitors. Type- l astrocytes 
and neurons produce PDGF (Yeh, et a i . ,  1 99 1 ;  Sasahara et ai . ,  1 99 1 ), which supports the 
idea for a regulatory role on OLG proliferation and differentiation in vivo. 
PDGF is a dimer of a cationic glycoprotein (30 kDa) and in the human, there are 
two distinct, but related polypeptides called A and B chains (Betsholtz et a i . ,  1 986). 
PDGF A transcripts were found in the type- I astrocyte (Richardson et ai . ,  1 988) and 
compared to other dimers, the AA homodimer appears to be the most potent mitogen for 
0-2A cells compared to other dimers (Pringle et a i . ,  1 989). There are two classes of 
1 3  
PDGF receptors, the A fonn which can bind all  three dimers, and the B fonn which has 
high affinity for the BB dimer, but low affinity for the AB (Hart et al . ,  1 988; Heldin et a l . ,  
1 988) .  Radiolabeled PDGF binding assays suggest that 0-2A cells have the A type 
PDGF receptor (Hart et al . ,  1 989). Interestingly, in the continued presence of PDGF, the 
0-2 A  precursors stop prol iferating and acquire characteristics of mature OLGs (Noble et 
a l . ,  1 988; Richardson et al . ,  1 988). However, this is not due to receptor loss, for the 0-
2A progenitor cells continue to express the PDGF alpha receptor (Hart et al . ,  1 989). 
Basic fibroblast growth factor (bFGF) has also been shown to be mitogenic for 
OLGs (Eccleston and Si lberberg, 1 985; Besnard et al . ,  1 989) as well as astrocytes 
(Pettman et a l . ,  1 985;  Kniss and Burry, 1 988). bFGF not only causes the 0-2A cells to 
undergo a high rate of proliferation (Noble et al . ,  1 988), it also maintains high levels of 
PDGF receptors on the 0-2A precursors (McKinnon et al . ,  1 990) .  An interesting 
observation is the lack of MBP transcripts after treatment with bFGF (McKinnon et al . ,  
1 990), which may suggest an inhibitory role for bFGF on myelin gene expression and/or 
OLG differentiation. Consequently, the combination of PDGF and bFGF causes 0-2A 
precursor prol iferation for long periods without differentiation (Bogler, et a l . ,  1 990) .  
It has been shown that insulin and insulin-like growth factors ( IGFs) are essential 
for the development of OLGs in vitro (van der Pal et al., 1 988). A role of these factors in 
vivo have come from the fact that transcripts for insulin-l ike growth factors, IGF-I and 
IGF-II have been found in the CNS, with the highest levels of gene expression coinciding 
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with early neuronal development (E I 4- 1 8) (Rotwein et aI . ,  1 988). IGF-I and IGF-II 
receptors have been detected in rodent brain as well as cultured astrocytes, OLGs, and 
0-2A progenitor cells (Gammeltoft et aI . ,  1 985; Balloti et a I . ,  1 987; Ocrant et aI . ,  1 988; 
McMorris and Furlanetto, 1 989). The importance of these factors have been shown in 
that low levels of IGF levels result in hypomyelination in vivo (Phil l ips and 
Vaffilopoulou-Sell in, 1 979;  Wiggins, 1 982). On the other hand, increased IGF expression 
is associated with increased myelination (Carson et aI., 1 988, McMorris et aI . ,  1 990) .  
OLGs contain high levels of iron, suggesting an important relationship between 
iron and the state/function of the OLGs (Connor and Menzies, 1 995) .  Consequently, it 
has been shown that transferrin, an iron mobilizing protein is an essential factor for 
myelination by OLGs (Espinosa de los Monteros et aI . ,  1 999) .  Iron plays a direct role in 
lipid and cholesterol biosynthesis by acting as a required co-factor and may have a 
protective function by regulating oxidative stress (Connor and Menzies, 1 996) .  The 
importance in understanding the combined information from the effects of all of these 
factors is seen in the advent of a chemically defined medium giving optimal conditions to 
grow OLGs in culture, thus enabling the further elucidation of factors that may regulate 
OLG development. 
C REB, a transcription factor highly expressed in developing OLGs 
Previous studies from this laboratory have shown that developing OLGs express 
elevated levels of a transcription factor known as CREB (cyclic AMP response element 
binding protein) (Sato-Bigbee and Yu, 1 993 ; Sato-Bigbee et al . ,  1 994 Sato-Bigbee and 
DeVries, 1 996) .  
CREB belongs to a large family of transcription factors characterized by the 
presence of a basic leucine zipper dimerization domain and their binding to a consensus 
nucleotide sequence TGACGTCA. This sequence is known as CRE (cyclic AMP 
response element) and it is present in the promoter region of cAMP and Ca2• responsive 
genes ( Montminy et al., 1 990; Sheng et a I . ,  1 99 1 ) . The ability of CREB to activate 
transcription is positively regulated by phosphorylation at a region called the P-box, 
specifically, a serine residue at position 1 33 .  
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CREB is encoded by a large gene that generates several alternatively spliced 
transcripts ( Hoeffler et a l . ,  1 990).  However, the 43 kDa CREB and a form known as 
�C REB , which is missing the alternatively spliced 1 4  amino-acid segment called the 
(X-region (Yamamoto et a l . ,  1 990), appears to be the predominant isoforms expressed in 
most of the tissues tested. Our previous results indicated that the CREB protein 
expressed in the OLGs contains the (X-region (Sato-Bigbee et al . ,  1 994). This is 
particularly important because this region interacts cooperatively with the 
phosphorylation motif which as indicated above is required for transcriptional activation. 
Moreover, it has been shown that the potency of �CREB as a transcriptional activator is 
1 0-fold lower than that of CREB (Yamamoto et al . ,  1 990). 
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Initially, C REB phosphorylation at SerilJ was attributed to cAMP-dependent 
protein kinase (PKA) (Gonzalez and Montminy 1 989). Thus, factors which elevate 
cAMP levels may result in the activation of PKA and the subsequent phosphorylation of 
CREB, leading to gene activation. However, later evidence indicated that CREB could 
be phosphorylated at SerilJ by several other kinases including Ca2'-calmodulin-dependent 
kinases (CamK) (Sheng et aI . ,  1 99 1 ), protein kinase C (PKC) (Xie and Rothstein, 1 995) ,  
and the ribosomal S6 kinase (RSK) (Xing et  aI . ,  1 996), which as  described later, is a 
target of the MAPK (mitogen activated protein kinase) pathway. 
In addition to the P-box, other structurally important domains in CREB are the 
glutamine rich regions flanking the P-box which are believed to play a role in interacting 
with other components of the transcription machinery (Gonzalez et a I . ,  1 99 1 ) . Of these 
two glutamine-rich domains (Q I and Q2) that flank the P-box, Q2 appears to have more 
of a significant role in the activation of transcription, for the deletion of Q2 dramatically 
reduces C REB function (Brindle et aI., 1 993) .  Furthermore, CREB also requires a 
cofactor called CBP (CREB-binding protein).  CBP is a 265 kDa protein that interacts 
with the phosphorylated P-box of CREB (Chrivia et aI . ,  1 993) .  The phosphorylation of 
SerilJ on CREB promotes the binding of CBP, which mediates CREB interaction with the 
RNA polymerase II complex. For full activity however, it  was demonstrated that the 
glutamine-rich region was necessary for its role in interacting with the general 
transcription factor TFIID (Nakaj ima et aI . ,  1 997).  
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As far as the negative regulation i s  concerned, i t  appears that the main mechanism 
attenuating transcriptional activation by CREB is dephosphorlyation. CREB is 
dephosphorylated in vivo by protein phosphatase- I (Hagiwara et aI . ,  1 992) and protein 
phosphatase-2 appears to have some activity as well (Wadzinski et a I . ,  1 993) .  Although 
the capacity of CREB to activate transcription is regulated by its phosphorylation, other 
factors can also have effects in regulating the function of this protein. While CREB 
stimulates transcription, certain forms of another transcription factor called CREM 
(cAMP response element modulator) work as competitive repressors (Foulkes et a I . ,  
1 99 1 ), as  does the lCER (inducible cAMP early repressor) proteins ( Molina et  a I . ,  1 993) .  
The C REM gene also generates a large family of alternatively spliced isoforms . 
C REM alpha, beta and gamma function as antagonists of CREB-induced transcription 
either by binding to CRE sites as homodimers or heterodimers, thus blocking activator 
binding to the CRE. This is possible due to the fact that structurally, these CREM 
isoforms are very similar to CREB as they also bind to the CRE sequence, but lack the 
glutamine rich domains required for transcriptional activation (Foulkes et a I . ,  1 99 1 ) . 
lCER, a truncated CREM product (Stehle et aI . ,  1 993 ; Molina et aI . ,  1 993) ,  is 
transcribed from an alternative promoter within an intron of the CREM gene and acts as a 
powerful repressor of CREB-induced transcription. lCER, which actually negatively 
autoregulates its own promoter (Molina et a I . ,  1 993), is able to heterodimerize with the 
CREM proteins as well as with CREB (Stehle et aI . ,  1 993) .  Thus, the fact that many of 
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these different CRE-binding factors are able to heterodimerize with each other (Hai et a I . ,  
1 989) makes the study of these proteins and their mechanism of action very complicated. 
Possible role of CREB in developing OLGs 
Studies from this laboratory in which CREB expression was analyzed in OLGs 
directly isolated from rat brain at different stages of development (Sato-Bigbee and Yu, 
1 993; Sato-Bigbee et aI. , 1 994) or in neonatal OLGs that were allowed to differentiate in 
vitro (Sato-Bigbee and DeVries, 1 996),  indicated that this protein is highly expressed in 
cells that are sti l l  MBP negative and have a typical morphology of immature OLGs. 
However, CREB expression decreases to background levels of detection in cells that 
express MBP and exhibit highly branched processes characteristic of mature OLGs. This 
pattern of expression suggested that in the OLGs, CREB plays a role in a developmental 
window that precedes the period of active myelination. 
While the activity of transcription factors like CREB occurs in the nucleus of the 
cel l ,  the stimuli  which activate such transcription factors are usually extracellular in 
origin. Thus, interaction of these external stimuli with the cells by means of specific 
l igand-receptor mechanisms that are coupled to different signal transduction cascades, are 
able to elicit changes in gene activity that regulate cell development. 
Recent results from this laboratory have suggested that CREB could be a mediator 
of neuronal signals that, coupled to different signal transduction pathways, may play 
1 9  
different roles at specific stages of OLG development (Sato-Bigbee et aI . ,  1 999a). We 
have found before that in committed OLGs, CREB activation by phosphorylation at Ser'JJ 
can be triggered by the beta-adrenergic agonist isoproterenol, which is known to increase 
cAMP levels in these cells .  In this regard, we have previously found that treatment of 
young but already committed OLGs with db-cAMP (a cell permeable analogue of cAMP) 
resulted in stimulation of MBP expression and cell process outgrowth. However, this 
stimulation was not observed in cells in which the expression of CREB was inhibited by 
transfecting the cells with an antisense oligonucleotide directed against CREB mRNA. 
Thus, these results indicated that CREB plays a crucial role in the stimulation of OLG 
differentiation by cAMP (Sato-Bigbee and De Vries, 1 996). Based on these observations, 
it  is possible to hypothesize that in young, but already "committed" OLGs, beta 
adrenergic stimulation fol lowed by PKA activation and CREB phosphorylation could be 
at least one of the signals triggering the final stages of OLG maturation. 
Interestingly, we have found that at an earlier developmental stage, when the cells 
are sti l l  "immature" OLG precursors, CREB phosphorylation is stimulated by the 
cholinergic agonist carbachol, glutamate and ATP; all neuroligands that increase Ca'+ 
levels in the cells .  In this case, CREB phosphorylation involved the action of a 
MAPKlPKC pathway. These latter results suggested that at this early developmental 
stage, CREB could p lay a role in regulating cell proliferation. This hypothesis is based 
on the observation that the MAPK pathway in OLGs is stimulated by neurotrophin-3 
(NT-3) ,  PDGF, and bFGF (Bhat and Zang, 1 996; Cohen et aI., J996a), al l  factors known 
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to stimulate OLG proliferation (Bogler et aI . ,  1 990; McKinnon et aI . ,  1 990; Barres et aI., 
1 99 3 ,  1 994). Thus, based on the results described above, we decided to test whether 
CREB could be a mediator of NT-3 action in OLGs. 
Neurotrophins and their signaling cascade pathway 
NT-3 is a member of a family of closely related peptide factors known as 
neurotrophins. Neurotrophins also include nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF), neurotrophin-4/5 (NT-4/5)  (Snider et aI . ,  1 989;  Eide et aI . ,  
1 99 3 )  and NT-6 (Gotz et aI . ,  1 994). These factors bind to and activate the Trk family of 
receptor tyrosine kinases. TrkA, TrkB, and TrkC are the receptors for NGF, BDNF and 
NT-3 ,  respectively (Thoen en, 1 99 1 ). TrkB also serves as a receptor for NT-4/5 
(Bothwell ,  1 99 1 ) . In the nervous system, neurotrophins affect a wide range of biological 
responses which include proliferation, differentiation, and survival of neuroblasts 
(Confort et a I . ,  1 99 1 ;  DiciccooBloom et aI . ,  1 993)  as well as the survival and development 
of neurons (Levi-Montalcini, 1 987;  Ghosh et aI . ,  1 994). The differentiation effects 
elic i ted by neurotrophins include enhanced neurite outgrowth (Segal et a I . ,  1 995) ,  
alterations in the electrophysiological properties of neurons as wel l  as enhanced synaptic 
transmission (Levine et aI . ,  1 995a; Levine et aI . ,  1 995b), and determination of the 
neuronal cel l  fate (S ieber-Blum, 1 99 1 ) . 
Neurotrophins are also known to affect the glial cells as they regulate the function 
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of cultured microglia (Nakajima et al . ,  1 998), and the morphological behavior of 
astrocytes in vitro (Hutton et al . ,  1 995) .  In vitro experiments have shown that NT -3 in 
particular appears to be important for OLG proliferation, development, and survival 
(Barres et a l . ,  1 994; Kumar et a l . ,  1 998) .  In vivo results from Kahn et al. ( 1 999) showed 
that knockout mice lacking the TrkC receptor or NT-3 resulted in fewer progenitor cells 
as well  as attenuated expression of OLG specific markers. Moreover, it has been shown 
that transplantation of NT -3 and BDNF producing fibroblasts into contused rat spinal 
cord ameliorated the axonal and myelin damage after spinal cord injury (McTigue et al . ,  
1 998) .  Furthermore, Heinrich e t  al .  ( 1 999) recently demonstrated that N T  - 3  aids i n  the 
early differentiation of OLGs in rat cortical cultures. 
The mechanisms of action of neurotrophins are sti l l  controversial as they seem to 
include the concerted actions of different signal transduction pathways, and this 
complexity may explain the variety of effects that these factors are able to elicit .  
The best studied example is the action of NGF on the rat pheochromocytoma cell  
line PC 1 2  (Kaplan et al . ,  1 99 1 ) . The binding of NGF to its receptor TrkA causes receptor 
dimerization and the activation of the intrinsic tyrosine kinase activity of TrkA (Jing et 
a l . ,  1 992) .  Once the receptor is  activated by auto-phosphorylation, the phosphotyrosines 
and the nearby amino acids of the receptor act as recognition sites for effector molecules 
that contain the Src homology 2 (SH2) domain. Among the proteins that have the SH2 
domains are the enzymes phospholipase C gamma (PLC y), phosphatidylinositol 3-
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kinase (P13 kinase) (Stephens et aI . ,  1 994; Obermeier et aI . ,  1 993), and the adapter protein 
Shc (Stephens et a I . ,  1 994). 
The MAPK pathway, critical for the NGF induction of PC 1 2  cell differentiation, 
is set into motion when the Shc adapter protein binds to its recognition site on the 
activated TrkA receptor. Shc then becomes phosphorylated by the receptor tyrosine 
kinase and serves as an adapter for yet another SH2 containing protein known as Grb2 
(growth factor receptor-bound protein 2) (Rozakis-Adcock et aI . ,  1 992) .  Grb2 has yet 
another structural motif called the Src homology 3 (SH3) domain (Lowenstein et aI . ,  
1 992),  which mediates i ts  association with the GTP exchange factor Sos (son of sevenless 
protein). Sos then activates a membrane bound G protein called Ras by exchanging GDP 
for GTP on Ras 
( McCormick, 1 994). The activated, GTP-bound Ras then interacts and activates the 
serine-threonine kinase Raf (Moodie et aI., 1 993) ,  which in tum phosphorylates a dual 
specificity threonine/tyrosine kinase called MEK (MAPKIErk kinase) (Jaiswal et aI . ,  
1 994). The substrates for MEK are MAP K I  and MAPK2 (mitogen-activated protein 
kinases I and 2, also known as Erks ( extracellular signal-regulated kinases) (Crews et aI . ,  
1 992) .  Once the MAPKs are activated, they are translocated into the nucleus (Chen et a I . ,  
1 992)  where they phosphorylate several transcription factors as wel l  as other kinases, i .e .  
the ribosomal S6 kinases (Rsk) (Chen et  a I . ,  1 993) .  I t  appears that the role of Rsks is to 
phosphorylate other transcription factors, one of which is CREB (Xing et a I . ,  1 996) .  
(Fig .  2) .  
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Figure 2. T h e  NGF stimulated MAPK pathway as described in the pe 12 cells.  This 
figure i l lustrates the proteins involved in activating the MAPK pathway in the PC 1 2  cells 
after NGF treatment. 
24 
The importance of CREB in the NGF induction of neuronal differentiation has 
been demonstrated by Bonni et al .  ( 1 995) .  However, a similar role for CREB in other 
cel ls of the CNS has never been described before. Thus, in the present study, we have 
investigated the possible role of CREB as a mediator of NT -3 actions in OLG precursor 
cells .  
MATERIALS AND METHODS 
Isolation and c u lture of oligodendrocytes. OLGs were isolated from 2-day-old 
Sprague-Dawley rat cerebrum by using a Percoll (Sigma Chemical Co. ,  St Louis, Mo) 
gradient according to the method of Berti-Mattera et al .  ( 1 984) with minor modifications 
(Sato-Bigbee et a I . ,  1 999a) .  The cerebra are minced and then dissociated in Ca2+ - Mg'+­
free Hanks' balanced salt solution (HBSS), 25 mM HEPES (pH 7 .2) ,  I mg/ml glucose, 
0 . 1 mg/ml DNAse and 1 mg/ml acetyltrypsin. After incubation for 45 minutes at 3 7 °C, 
the tissue is forced through a 74 jlm pore size nylon mesh and the resulting cell  
suspension is mixed with 1 . 5 vol.  isosmotic Percoll and centrifuged at 3 0,000 x g for 1 5  
minutes. The band corresponding to the OLGs and their precursor cells is collected, 
washed with HBSS, and the final cell suspension incubated for 30 minutes on tissue 
culture-treated Petri dishes to allow the attachment of residual microglial and astrocyte 
contamination (-5 - 1 0%).  The dishes were then gently swirled for 1 0  seconds and the 
non-adherent cells plated in 24-wel l  plates ( I  x I 06 cells/well)  previously coated wit 
reduced-growth factor Matrigel (Becton Dickinson, NJ, USA) ( 1 0  jll/wel l ) .  Cells were 
grown in chemically-defined medium (CDM) [Dulbecco's modified Eagle's medium 
(DMEM)/Ham F- 1 2  medium ( 1 : 1 ,  vol/vol) supplemented with I mg/ml bovine serum 
albumin, 50 jlg/ ml transferrin, 5 mg/ml insulin, 30 nM sodium selenite, 0 . 1 1  mg/ml 
sodium pyruvate, 1 0  nM biotin, 2 jlM hydrocortisone, 1 5  nM triiodothyronine, 5 0  
units/ml penic i l l in, and 50 jlg/ml streptomycin] a t  3 7 °C i n  5% CO,. Cultures prepared i n  
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this way are comprised of OLG precursor cells that are either bipolar or have several 
simple processes and can be labeled with the 04 (Sommer and Schachner, 1 98 1 )  and lor 
the A2B5 (Levi et aI . ,  1 987) antibodies. Astrocyte contamination, as judged by staining 
with anti-glial fibri l lary acidic protein antibody, was < 5%. Neuronal contamination as 
determined by staining with anti-neurofilament antibody was < 1 %. 
Effect of NT -3 on CREB and MAPK phosphorylation. After one day in culture, 
OLGs were incubated for various times in CDM with or without 50 nglml human 
recombinant NT-3 (Pepro Tech Inc. ,  Rocky Hill ,  NJ) .  After incubation, the cells were 
rinsed with ice-cold DMEM and processed for western blot analysis to determine the 
relative levels of total CREB, phosphorylated CREB and MAPK as described below. In 
experiments aimed to determine the role of different protein kinases, the cells were pre­
incubated for 1 0  minutes in the presence of the fol lowing specific kinase inhibitors : 50 
flM PD098059 (MEK inhibitor); 10 flM chelerythrine (PKC inhibitor), 0 .5  flM H-89 
(PKA inhibitor), 3 0  flM KN-62 (CamK II ,  IV and V inhibitor), or 10 mM L Y294002 (P13 
kinase inhibitor). Al l  inhibitors were obtained from Calbiochem (San Diego, CA). After 
this, culture were incubated for I S  minutes in the presence or absence of both NT -3 and 
kinase inhibitor. Inhibitor concentrations are higher than IC,o values for the purified 
enzymes, but are in agreement with the concentrations previously used by us and other 
investigators to specifically inhibit these kinases in cell culture systems (Balboa and Insel, 
1 99 5 ;  Campenot et aI., 1 994; Maurer et aI., 1 996; Muthalif et aI., 1 996;  Sato-Bigbee et 
aI . ,  1 999b). 
27 
Western blot an alysis. OLG cultures containing equivalent number of cells per well 
were lysed in 1 00 III of 60 mM Tris-HCl buffer (pH 6.8) containing 1 0% glycerol, 2% 
sodium dodecyl sulfate (SDS), and 5% 2-mercaptoethanol. The samples were frozen and 
stored at -70°C until required. Fifteen III samples were subjected to SDS-polyacrylamide 
gel electrophoresis in 1 2% acrylamide gels and the proteins were then electrotransferred 
to nitrocellulose membranes. The membranes were then subjected to immunoblot 
analysis .  Non-specific antibody binding to the blots was blocked by incubation in buffer 
containing 1 0  mM Na.,HPO" 2 .7  mM KC1, 1 3 7  mM NaCI (PBS);  3% non-fat dry milk; 
0 . 05% Tween 20 (pH 7.4) (blocking solution), for 1 hour at room temperature. The blots 
were then incubated overnight with either a total CREB (phosphorylated and non­
phosphorylated protein) anti-CREB monoclonal antibody (dil .  I : 500) (Santa Cruz 
Biotech. ,  Santa Cruz, CA) or a phosphorylated CREB antibody which recognizes CREB 
when phosphorylated at Ser'3J (Ginty et al., 1 993) (di l .  I :  1 000) (Upstate Biotech. inc . ,  
Lake Placid, N Y ) .  Phosphorylated MAPKs were detected using an antibody that 
specifically recognizes p42 and p44 MAPKs when phosphorylated at Tyr204 (dil .  I :  1 000) 
(Santa Cruz Biotech. ) .  The b lots were then incubated with the appropriate secondary 
horse radish peroxidase ( HRP)-conjugated antibody (monoclonal anti-mouse IgG (di l .  
1 : 2000) for total CREB and MAPK; polyclonal anti-rabbit IgG (di l .  I :  1 000) for 
phosphorylated C REB). After two 5 minute rinses of the blots with PBS containing 
0 . 05% Tween 20 and three 5 minute rinses in PBS, the immunoreactive bands were 
revealed by a chemiluminescence reaction with SuperSignal Ultra reagents (Pierce, 
Rockford, IL). The relative amount of immunoreactive protein in each band was 
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determined by scanning densitometric analysis of the X-ray films. 
D iacylglycerol Assay. OLG cultures were incubated for 1 0  minutes in CDM with or 
without 50 ng/ml NT-3 . At the end of the incubation, the cultures were rinsed with ice­
cold DMEM, transferred to ice, and the cells rapidly scraped off the plates and 
homogenized in phosphate buffer saline solution (PBS).  Aliquots of the ceil lysates were 
used to determine the concentration of sn- I ,2-diacylglycerol (DAG) using an assay kit 
from Amersham (Arlington Heights, IL), according to the manufacturer's 
recommendations. This assay utilizes E. Coli DAG kinase and allows the quantitative 
conversion of the DAG present in the cells to [12PJphosphatidic acid in the presence of 
I n hibition of CREB p rotein expression. CREB protein synthesis was inhibited by 
using a deoxyoligonucleotide directed against CREB mRNA as previously reported 
(Sato-Bigbee and DeVries, 1 996) with minor modifications. Deoxyoligonucleotides 
corresponding to the CREB- I sequence (Gonzalez et aI . ,  1 989a) in the antisense ( 5'-GC 
TCC AGA eTC CAT GGT CAT-3')  and sense (5 '-ATC ACC ATG GAC TCT GAA GC-
3') orientations, spanning the initiation codon to nucleotide 20, were prepared by Ransom 
Hil l  Bioscience (Ramona, CA). Transfection was carried out by using Lipofectamine 
P lus™ reagent (GIBCO BRL, Gaithersburg, MD). Sense or antisense oligonucleotides ( 1  
flg/well)  were incubated for I S  minutes with 5 fll Plus reagent fol lowed by 1 5  minutes 
with 1 .25  fll Lipofectamine. Cells were then incubated overnight with the 
oligonucleotide mixture in DMEM : HAM F- 1 2  ( 1 : 1  v/v). CREB expression after 
transfection was assessed by western blot analysis using anti-total CREB antibody as 
described above. 
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Proliferation assay. After transfection, the medium was replaced by CDM containing 
0 . 5  IlCi/ml ['H]thymidine (75Ci/mmol, Amersham), in the presence or absence of 50 
ng/ml NT -3 . At the end of an 1 8  hour incubation period, the cultures were washed three 
times with ice-cold PBS and the cells were solubilized in 500 III 0.2N NaOH. The DNA 
was precipitated with 20% trichloroacetic acid (TCA) and the pellet was washed four 
times with 5 % TCA. After solubil ization of the pellet by incubation with 70% perchloric 
acid at 
3 7 °C for 1 hour, the radioactivity was determined by liquid scinti llation counting. 
Statistical analysis. Statistical analysis was performed by one-way ANOV A. 
Differences were considered statistically significant when p values were < 0 .05 .  
RESULTS 
Treatment of n eonatal OLG precursor cells with NT-3 results in  stimulation of 
C REB p h osphorylation. 
As indicated before, previous results from this laboratory indicated that CREB 
phosphorylation in "immature" OLG precursors could be regulated by agents which 
stimulate a MAPK pathway. In order to investigate whether NT-3 , which is known to 
activate MAPK in OLGs, could also regulate CREB activation in these cells, cultures of 
OLG precursors were incubated for various times in chemically defined medium 
containing 50 ng/ml NT-3 .  At the end of each incubation time, the cells were lysed and 
the levels of C REB phosphorylation were investigated by western b lot analysis. In these 
experiments, we have used an antibody that specifically recognizes CREB only when 
phosphorylated at SerJJJ .  As indicated before, phosphorylation of CREB at SerJJJ is a 
requirement for this transcription factor to activate transcription. 
Figure 3 shows that NT -3 treatment results in a rapid increase in the levels of 
CREB phosphorylation reaching a peak at 1 5  minutes and remaining elevated even after 
45 minutes of incubation time. Consequently, future experiments investigating the 
signaling pathways leading to CREB activation utilized 1 5  minute incubation times. 
To demonstrate that these results signified a true increase in CREB 
phosphorylation levels, as opposed to increased expression of the CREB protein itself, 
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Figure 3.  Treatment of OLG precursors with NT-3 results in stimulation of CREB 
phosphorylation. After 1 day in culture, OLGs were incubated for various t imes in the 
presence of 50 ng/ml NT-3 . Phosphorylated CREB (P CREB) was detected by western 
blot analysis with an antibody that specifically recognizes CREB when phosphorylated at 
SerlH Total CREB was detected using an antibody that detects both phosphorylated and 
non-phosphorylated CREB. (A) representative western blot, each lane corresponds to 1 0  
flg of cel l  lysate protein. (B) P CREB levels were detennined by scanning densitometry 
of the bands. The results are expressed as % of the control values in the absence of NT-3 
and represent the mean±SEM from 3-4 independent experiments. *0 min vs. 5, 1 5 , 45 
min: p<O.OO l .  
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parallel western blots were performed using an antibody that recognizes total CREB 
protein levels, this is both the phosphorylated and non-phosphorylated forms of CREB. 
As shown in figure 3, incubation of the cultures in the presence of NT-3 did not affect the 
levels of total CREB protein, indicating that the observed increase in phospho-CREB 
levels directly reflect increased phosphorylation. 
The MAPK and PKC pathways play a significant role in the NT-3 dependent 
stimulation of CREB p hosphorylation. 
Based on the results described above we decided to investigate the signal 
transduction pathway(s) mediating the stimulation of CREB phosphorylation in the cells 
treated with NT-3 . 
For this purpose, cultures of OLG precursor cells were incubated in medium 
containing NT-3 in the presence or absence of cell permeable specific kinase inhibitors . 
The possible role of a MAPK pathway was studied by co-incubation of the cells in the 
presence o f P D098059.  This compound inhibits MEK, the kinase that phosphorylates 
and activates MAPK. As shown in figure 4, incubation in the presence of this inhibitor 
decreases the NT-3 dependent stimulation of CREB phosphorylation by about 23%. 
Interestingly, incubation in the presence of chelerythrine, a specific inhibitor of 
PKC, also resulted in a significant reduction (- 36%) in the NT-3 dependent stimulation 
of CREB phosphorylation. Most importantly, we observed that CREB phosphorylation in 
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Figure 4 .  The NT-3 dependent stimulation of CREB phosphorylation in OLGs involves 
the action of MAPK- and PKC- signaling pathways. 
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Figure 4 .  T h e  NT - 3  dependent stimulation o f  C R E B  p hosphorylation in OLGs 
involves the action of MAPK- and PKC -signaling pathways. After 1 day in culture, 
the cells were preincubated for 1 0  minutes under the fol lowing conditions: (a) and (b) :  
medium alone;  (c) 5 0  IlM PD098059 (MEK inhibitor); (d) 10 IlM chelerythrine (PKC 
inhibitor); or (e) 5 0  IlM MEK inhibitor + 1 0  IlM PKC inhibitor. Cultures were then 
incubated for 1 5  minutes in (a) medium alone (control);  (b) 50 nglml NT-3;  (c) 50 nglml 
NT-3 + 50 IlM MEK inhibitor; (d) 50 nglml NT-3 + 1 0  IlM PKC inhibitor; or (e) 50 
nglml NT -3 + 5 0  IlM MEK inhibitor + 10 IlM PKC inhibitor. After incubation, 
phosphorylated CREB (P CREB) levels were determined by western blot analysis. 
(A) representative western blot, each lane corresponding to 1 0  Ilg of cell lysate protein.  
(B)  P CREB levels are expressed as % of the controls in the absence of NT-3 and 
represent the mean±SEM from 3-5 independent experiments. Control vs. NT -3 : p<O .OO I ;  
NT-3 vs.  NT-3 + MEK inhibitor: p<0 .05 ;  NT-3 vs. NT-3 + PKC inhibitor: p<0 .05 ;  NT-3 
vs. NT -3 + MEK inhibitor + PKC inhibitor: p<O .OO 1 .  
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the presence of NT-3 was dramatically decreased, by about 70%, when the M E K  and 
PKC inhibitors were used simultaneously. This observation suggested the possibility of a 
concerted mechanism between the MAPK and PKC pathways. 
To test this possibi l i ty, we investigated the role of both MEK and PKC in 
mediating the activation of MAPK by NT-3 .  In these experiments MAPK 
phosphorylation was investigated by western blot analysis using an antibody that 
specifically recognizes MAPK 42 and MAPK 44 when phosphorylated at Tyr204. 
Our data showed that incubation in the presence of NT-3 resulted in a dramatic 
increase in the phosphorylation of MAPK. Inhibiting MEK, however, decreased this 
stimulation by about 50%. Interestingly, inhibition of PKC also reduced MAPK 
phosphorylation in the presence of NT-3 by - 5 0%, suggesting that, in addition to MEK, 
P KC also plays an integral role in the pathway that leads to the activation of MAPK by 
NT-3 . Further evidence for a concerted mechanism is supported by the observation that 
incubation in the presence of both MEK and PKC inhibitors completely blocked the NT-
3 mediated stimulation of MAPK phosphorylation. (Fig. 5 ) .  
To further support the participation of a PKC activity in  the pathways triggered by 
NT-3 , we investigated whether incubation with this neurotrophin could affect the levels 
of possible activators of PKC. As shown in figure 6, treatment of the cells with NT-3 
resulted in a significant increase in the intracellular levels of diacylglycerol (DAG). 
Thus, it may be possible to speculate that this increase in DAG results in PKC activation; 
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Figure 5. MAPK activation in OLGs treated with NT-3 is coupled to both MEK and 
PKC activities. After I day in culture, cells were pre-incubated for 10 minutes under the 
fol lowing conditions: (a) and (b) :  medium alone; (c) 50 f-LM PD098059 (MEK inhibitor); 
(d) 1 0  f-LM chelerythrine (PKC inhibitor); or (e) 50 f-LM MEK inhibitor + 1 0  f-LM PKC 
inhibitor. Cultures were then incubated for 1 5  minutes in (a) medium alone ; (b) 5 0  
ng/ml NT-3 ; ( c )  5 0  nglml NT-3 + 50 f-LM MEK inhibitor; (d) 50 ng/ml NT-3 + 1 0  f-L M  
P KC inhibitor; or ( e )  5 0  ng/ml NT-3 + 50 f-L M  MEK inhibitor + 1 0  f-LM PKC inhibitor. 
Western b lot analysis was then used to detect p42 and p44 MAPK Tyr phosphorylation . 
(A) representative western blot, each lane corresponding to 1 0  f-Lg of cell lysate protein. 
(B) levels of phosphorylated MAPK were expressed as % of the control values in the 
absence of NT-3 and represent the mean±SEM from 3 independent experiments. Control 
vs. NT-3 : p<O.OO I ;  NT-3 vs. NT-3 + MEK inhibitor: p<O.OO I ;  NT-3 vs. NT-3 + PKC 
inhibitor: p<0.02;  NT-3 vs. NT-3 + MEK inhibitor + PKC inhibitor: p<O.OO I .  
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Figure 6. Treatment of OLG precu rsors with NT -3 results in increased levels of 
diacylglycerol (DAG). After 1 day in culture, cells were pre-incubated for 1 0  minutes in 
the presence or absence of 50 ng/ml NT -3 . At the end of the incubation, DAG 
concentration in the cells (5x 1 O· cel ls/sample) was determined as indicated under 
"Methods." The results represent the mean±SEM from 3 independent determinations. 
* Control vs . NT-3 : p<0 .05 .  
this step being one of the events mediating the action of NT -3 on OLGs. 
Since the inhibition of both MEK and PKC drastically decreased, but not 
completely abolished CREB phosphorylation, it is possible that other kinases may also 
play a minor role in mediating CREB activation by NT-3 . In order to identify other 
possible kinase(s) involved in this stimulation, we carried out additional inhibition 
studies. 
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The possible role of PKA was investigated by co-incubation of the cells in the 
presence of its specific inhibitor H-89. On the other hand, the possible role of CamK and 
PI3-kinase was studied by treatment with their specific inhibitors KN-62 and L Y294002, 
respectively. Figure 7 suggests that these kinases may not play a significant role in 
mediating CREB phosphorylation by NT-3 . However, further studies are required for 
more conclusive results about these kinases. 
Thus, the question still remains open as whether there may be a yet unidentified 
kinase(s) that may play a minor role in mediating the phosphorylation of CREB under 
NT-3 stimulation. 
BOO 
700 
::J' 600 0 0::: t-
Z 500 0 U 
LL. 400 0 
� 300 m w 0::: U 200 
a.. 
1 00 
a 11 
(a)  
0"" 
�� cP 
i1- i1-� 
42 
r-l-
Figure 7. The NT -3 dependent stimulation of CREB phosphorylation in OLGs does not 
appear to involve the PKA, CamK, nor the PI3K pathways. 
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Figure 7. The NT-3 dependent stimulation of CREB phosphorylation in OLGs does 
not appear to involve the PKA, CamK, nor the PI3K pathways. After 1 day in 
culture, the cells were preincubated for 1 0  minutes under the fol lowing conditions: (a) 
and (b): medium alone; (c) 0.5 flM H-89 (PKA inhibitor); (d) 30  flM KN-62 (CamK II, 
IV and V inhibitor); (e) 10 flM LY294002 (PI3 kinase inhibitor). Cultures were then 
incubated for 1 5  minutes in (a) medium alone (control) ;  (b) 50 ng/ml NT-3;  (c) 50 ng/ml 
NT-3 + 0 . 5  flM PKA inhibitor; (d) 50 ng/ml NT-3 + 30 flM CamK inhibitor; (e) 50 
ng/ml NT -3 + 1 0  flM PI3 kinase inhibitor. After incubation, phosphorylated CREB (P 
CREB) levels were determined by western blot analysis. P CREB levels are expressed as 
% of the controls in the absence of NT-3 and represent the mean±SEM from 2-3 
independent experiments with each experiment having a minimum of 2 individual 
samples. NT-3 vs. NT-3 + PKA inhibitor: not significant; NT-3 vs. NT-3 + CamK 
inhibitor: not significant; NT-3 vs. NT-3 + PI3K inhibitor: not significant. 
I n hibition of CREB expression abolishes the NT -3 dependent stimulation of DNA 
synthesis in  OLGs. 
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As described before, results from different laboratories have indicated that NT-3 
stimulates the proliferation of OLG precursor cells in vitro as well as in vivo (Barres et 
a I . ,  1 994; McTigue et a I . ,  1 998 ;  Kumar et al . ,  1 998) .  Thus, the results described above 
raise the question of whether CREB could play a role in mediating that stimulation. 
To test this possibil ity, CREB expression in the OLG cultures was inhibited by 
using an antisense oligodeoxynucleotide sequence directed against CREB mRNA. For 
this, an oligonucleotide probe corresponding to the CREB sequence was prepared in the 
antisense (5'-GC TCC AGA GTC CAT GGT CAT-3') and sense (5 '-ATG ACC ATG 
GAC TCT GGA GC-3') orientations, spanning the initiation codon to nucleotide 20. 
Control cultures were treated with a CREB sense oligodeoxynucleotide. In these 
experiments, the uptake of the oligonucleotides was facil itated by using a cationic 
liposome preparation. Al l  conditions, including cell number, concentrations of 
oligonucleotides and transfection reagents, and incubation times were optimized to reach 
maximal levels of inhibition of CREB expression. The effectiveness of treatment with 
the antisense construct in inhibiting CREB expression was evaluated by western blot 
analysis .  In these experiments, we use an antibody that recognizes total CREB, both 
phosphorylated and non-phosphorylated forms. 
As shown in figure 8, the expression of CREB was drastically reduced in the 
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Figure 8. I n h ibition of CREB expression in OLG cultures. CREB expression was 
blocked by transfection with an antisense oligodeoxynucleotide (A ODN) directed against 
CREB mRNA, as indicated under "Methods." Control cultures were treated in a simi lar 
manner but in the presence of the cOITesponding construct in the sense orientation (S 
ODN). CREB expression after transfection was determined by western blot analysis with 
an antibody that recognizes both phosphorlyated and non-phosphorylated CREB. (A) 
representative western blot, each lane corresponding to 10 f..Lg of cell lysate protein. (B) 
C REB levels are expressed as % of the values corresponding to the control cel ls  (S ODN) 
and represent the mean±SEM from 4 experiments. 
* S ODN vs. A ODN: p<O.OO I .  
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antisense-treated cells compared to the sense strand treated control cells. 
eH]thymidine incorporation into DNA was then used to assess the effect of NT-3 
on the prol iferation of OLGs expressing either normal (sense-treated cells) or reduced 
(antisense-treated) C REB protein levels. 
As shown in figure 9,  incubation of the sense-treated OLG precursor cells with 
NT -3 resulted in a significant stimulation of DNA synthesis. However, this stimulation 
in DNA synthesis after NT -3 incubation was not seen in the antisense-treated cultures 
which, as shown before, expressed very low levels of CREB. Furthermore, CREB does 
not seem to have an important role as a regulator of the basal levels of DNA synthesis, for 
inhibition of CREB expression in cultures without NT-3 treatment did not appear to have 
any significant effects on [3H] thymidine incorporations. Altogether, these results support 
the idea that CREB is an important mediator in the stimulation of OLG proliferation by 
NT-3 . 
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Figure 9. I n h ib ition of CRE B expression abolished the NT-3 dependent stimulation 
of DNA synthesis in  OLGs. CREB expression was inhibited by transfection with CREB 
antisense ol igodeoxynucleotide (A ODN). Control cells were treated with the 
corresponding sense construct ( S ODN). Eighteen hours after transfection, the cell 
cultures were incubated for 1 8  hours in medium containing ['H] thymidine in the 
presence or absence of 5 0  ng/ml NT -3 . [JH] thymidine incorporation into DNA was 
determined as described under "Methods ."  The results are expressed as % of the values 
corresponding to the cells treated with S ODN in the absence of NT-3 (controls) and 
represent the mean±SEM from 5 experiments. 
* S ODN vs. A ODN + NT-3 :  p<0.02.  
DISCUSSION 
Results from Finkbeiner et al .  ( 1 997) indicated that in neurons, CREB is a key 
regulator in the induction of gene expression by BDNF, suggesting that CREB plays an 
important role in mediating neurotrophin responses in those cells. 
However to our knowledge, a similar role for CREB in other cells of the CNS has 
not been studied before. Our present results provide the first evidence that this 
transcription factor also plays a crucial role in mediating the action of another 
neurotrophin, NT-3 , in OLG precursor cells .  
Our studies demonstrated that treatment of OLG precursors with NT-3 results a in 
rapid and dramatic stimulation of CREB phosphorylation. Moreover, inhibition of CREB 
expression in the OLG precursors abolished the stimulation of DNA synthesis that is 
observed when the cells are incubated with NT-3.  Altogether, these results suggest that 
CREB activation is an important step in the signaling pathway(s) that triggered by NT-3 , 
result i n  stimulation of OLG proliferation. 
Our results indicated that in the OLGs, the stimulation of CREB phosphorylation 
by NT-3 appears to require the concerted action of MAPK- and PKC-mediated pathways. 
Based on the results previously reported by Xing et al. ( 1 996), we could speculate that the 
most likely mechanism linking MAPK to CREB phosphorylation when the OLGs are 
treated with NT-3 , is a MAPK-dependent activation of Rsk2 which could in tum 
phosphorylate C REB. 
As indicated above we have found that, in addition to a MAPK pathway, CREB 
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phosphorylation in OLGs treated with NT-3 also involves a PKC activity. This is in 
contrast with the observation from Finkbeiner et al .  ( 1 997) showing that in neurons, the 
stimulation o f C REB phosphorylation by BDNF is mediated by MAPK- and CamK­
dependent pathways. Consistent with the involvement of a CamK, these authors have 
found that treatment of cortical neurons with BDNF results in a slowly developing but 
sustained increase in cytosolic Ca2+ levels. To support a role for PKC in our cells, we 
have found that NT-3 was able to elicit an increase in the concentration of DAG. This 
increase in DAG could result in PKC activation. 
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In support of this possibil ity, our present results suggested that in the presence of 
NT-3 , a PKC activity is involved in mediating not only CREB phosphorylation but also 
the activation of M APK by Tyr phosphorylation. In this regard, results from different 
laboratories have previously shown a role for PKC in the activation of MAPK in OLGs in 
response to different conditions, including muscarinic receptor stimulation (Larocca and 
A lmazan, 1 997;  Pende et a l . ,  1 997),  activation of glutamate receptor channels (Pende et 
a l . ,  1 997) ,  and p latelet-derived growth factor (PDGF) and basic fibroblast growth factor 
(bFGF) (Bhat and Zhang, 1 996). 
P KC could directly phosphorylate Raf, which could then activate MEK resulting 
in MAPK phosphorylation (Kolch et a l . ,  1 993 ;  Marquardt et al . ,  1 994; Ueda et al . ,  1 996) .  
However, PKC may also modulate the MAPK pathway by different mechanisms in 
different cell types. It has been suggested that sites of PKC action, other than Raf 
activation, are likely to be effective at different points of the MAPK pathway as well 
(Cobb and Goldsmith, 1 995) .  
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Miranti et a ! .  ( 1 999) demonstrated that the alpha, delta and epsilon isoforms of  
PKC led to the activation of p42 MAPK by possibly regulating the Tyr phosphorylation 
of Shc in Cos 7 cells. Moreover, others have demonstrated that PKC can lead to the 
activation of MAPKs independent of many of the factors in the MAPK pathway, i .e .  Ras, 
Raf, and MEK (Ueda et a! . ,  1 996; Chao et a! . ,  1 994; Grammar et a! . ,  1 997) .  However, the 
direct role  that PKC plays in such cascades has yet to be elucidated. 
Thus, i t  appears that the site where PKC is involved in the MAPK pathway may 
be variable.  In our experiments, we have seen that MAPK phosphorylation is completely 
abo lished only when both MEK and PKC are inhibited simultaneously. On the other 
hand, individual inhibition of either MEK or PKC only decreased the phosphorylation by 
50%. These observations suggest that PKC is not working upstream of MEK because 
then the inhibition of MEK alone should produce the same result as inhibiting both MEK 
and PKC simultaneously. Furthermore, we know, by the antibody used in the western 
blots, that the M APKs are phosphorylated at a Tyr residue. Thus, the possibil ity of a 
direct phosphorylation of MAPK by PKC is eliminated by the fact that PKC is a 
serine/threonine kinase. Thus, the possibil ity exists of a yet unidentified step which may 
link P KC with MAPK activation by Tyr phosphorylation. 
Further complications in studying PKC signaling pathways stem from reports 
indicating the existence of several isoforms and differential cellular distributions of PKC 
(S lepko et a ! . ,  1 999) .  It appears that in the OLGs, PKC isotypes are differentially 
expressed according to developmental stages. Asotra and Macklin ( 1 994) reported that in 
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0-2A progenitors, only the Ca2+-independent PKC-delta, -epsilon and -zeta forms are 
expressed while other isotypes can be detected at later stages. The particular isoform of 
PKC appears to be critical in determining the physiological function effected by the 
kinase since Corbit et ai .  ( 1 999) reported that the aid of PKC delta in MAPK activation in 
PC 1 2  cel ls is related to neurogenic functions, but not to a mitogenic response. Studies 
investigating PKC activation have shown that PKC can be calcium dependent as well as 
calcium independent (Huang et aI . ,  1 993) .  Ohmichi et ai . ( 1 993)  demonstrated that NGF 
stimulation of PC 1 2  cells,  which also stimulated the production of DAG, selectively 
activated the calcium-insensitive epsilon isoform of PKC. This report is similar to our 
findings in that NT-3 stimulation of OLG precursor cells resulted in elevated levels of 
DAG, which may activate PKC. Thus, further experiments are necessary to determine the 
precise mechanism by which PKC could stimulate MAPK activation in the OLGs in the 
presence of NT-3 and how these two signaling pathways interact to mediate the NT-3 
dependent stimulation of CREB phosphorylation in the OLGs. 
Previous results from this laboratory suggested that in committed OLGs, CREB 
plays an important role being at least one of the mediators in the stimulation of OLG 
differentiation by cAMP (Sato-Bigbee and DeVries, 1 996). However, later studies 
investigating the regulation of CREB phosphorylation along OLG maturation raised the 
possibi lity that this transcription factor may play different roles by mediating the action of 
different signaling pathways at specific stages of cell differentiation (Sato-Bigbee et aI . ,  
1 999a).  Our present results support the idea that in the immature OLG precursors, CREB 
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plays an important role in transducing signals, which like NT-3, may regulate cell 
proliferation. In effect, previous results have shown that CREB phosphorylation in OLG 
precursors can also be stimulated by a MAPK pathway triggered by PDGF, bFGF (Pende 
et a I . ,  1 997) and the cholinergic agonist charbachol (Pende et aI . ,  1 997; Sato-Bigbee et 
a I . ,  1 999a); all factors known to promote OLG proliferation (Bogler et aI., 1 990; 
McKinnon et aI . ,  1 990; Cohen et aI . ,  1 996b). Thus, it  is possible to hypothesize that 
CREB could be a common mediator of signals which, by activating the MAPK pathway 
results in C REB phosphorylation and stimulation of OLG proliferation. Therefore, we 
are currently focusing on identifying the gene(s) that may be regulated by CREB 
mediating the stimulation of OLG proliferation. 
Our preliminary results indicated that treatment of OLGs with NT -3 also results in 
increased levels of c-fos (Sato-Bigbee et a I . ,  1 999a), a protein for which elevated 
expression has been linked to OLG proliferation (Bhat et aI . ,  1 992; Cohen et aI . ,  1 996b). 
It has been shown that in PC 1 2  cells, CREB interacts with other transcription factors 
mediating the stimulation of c-fos expression by NGF (Bonni et aI . ,  1 995) ;  and in neurons 
CREB by itself can mediate the up-regulation of c-fos expression by BDNF (Finkbeiner 
et a I . ,  1 997) .  Thus, CREB could in part mediate the up-regulation of c-fos expression 
that we have observed in the OLGs treated with NT-3 .  Interestingly, it  is possible to 
hypothesize that C REB itself and c-fos could simulate the expression of several proteins 
that are crucial for cel l  proliferation to occur. One of these proteins is the proliferating 
cel l  nuclear antigen (PCNA), an essential factor for DNA polymerase. It has been shown 
that PCNA promoter activity in interleukin 2-stimulated T lymphocytes largely depends 
5 5  
o n  the presence o f  tandem CREB binding sites (Huang e t  aI . ,  1 994). Moreover, Lee and 
M athews ( 1 997) demonstrated that CREB acts as a transcriptional coactivator capable of 
mediating the induction of human PCNA promoter by the adenovirus E I A  oncoprotein. 
Another possibil ity is that CREB may be involved in the regulation of genes encoding 
cyclins. Cyclins comprise a family of proteins which interact with and activate a series of 
kinases known as cyclin-dependent kinases or cdks (Pines, 1 993) .  In recent years it has 
ben shown that cdks catalyze phosphorylation events which are critical for the regulation 
of eukaryotic cel l  proliferation (Norbury and Nurse, 1 992; Pines, 1 993) .  In this regard, 
studies in human fibroblasts and muscle cells suggested that CREB and c-fos could play 
an important role i n  the cell cycle regulation of cyclin A expression (Desdouets et aI . ,  
1 99 5 ;  Sylvester e t  aI . ,  1 998) .  In addition, studies of  cyclin D gene promoter 
characterization and regulation suggested a role for CREB and c-fos in cyclin D 
expression (Yang et aI . ,  1 996; Jun et aI . ,  1 997; Brown et aI . ,  1 998) .  However, the 
possibility of similar roles for CREB or c-fos in the OLG has not yet been investigated. 
In summary, our present results indicated that CREB phosphorylation is at least 
one of the down-stream consequences of the NT-3 dependent activation of MAPK and 
PKC signaling pathways in OLG precursor cells. Moreover, CREB appears to play a 
crucial role in the stimulation of OLG proliferation by NT -3 . Further experiments would 
determine whether these mechanisms are also operational in vivo. A better understanding 
of these regulatory systems and their final targets should provide important clues to 
design strategies to stimulate OLG proliferation and remyelination after demyelinating 
lesions of the CNS. 
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